Scientific studies suggest that CBD may be effective against several TREs stemming from Dravet syndrome, Lennox-Gastaut syndrome, Tuberous sclerosis complex, Febrile infection-related epilepsy syndrom . . .

CBD has extremely low toxicity and no adverse effects with short-term use. On rare occasions, mild to moderate adverse effects have been shown, with long-term use.

Current research theorizes that the main function of the ECS in the skin is to regulate the proliferation, differentiation, survival, and the immune tolerance of skin cells.

The dose of CBD (as any other pharmacological drug) is directly linked to its route of administration. The following guidelines are based on the best currently-available scientific literature.